Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'nucleoside reverse transcriptase inhibitors' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 37 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mulligan, K; Tai, VW; Algren, H; Abrams, DI; Leiser, RJ; Lo, JC; Schambelan, M
      Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Pereira, AS; Tidwell, RR
      Separation methods for nucleoside analogues used for treatment of HIV-1 infection

      JOURNAL OF CHROMATOGRAPHY B
    3. Shulman, N; Zolopa, AR; Passaro, D; Shafer, RW; Huang, W; Katzenstein, D; Israelski, DM; Hellmann, N; Petropoulos, C; Whitcomb, J
      Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy

      AIDS
    4. Ghani, AC; Henley, WE; Donnelly, CA; Mayer, S; Anderson, RM
      Comparison of the effectiveness of non-nucleoside reverse transcriptase inhibitor-containing and protease inhibitor-containing regimens using observational databases

      AIDS
    5. John, M; Moore, CB; James, IR; Nolan, D; Upton, RP; McKinnon, EJ; Mallal, SA
      Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

      AIDS
    6. Brinkman, K
      Management of hyperlactatemia: no need for routine lactate measurements

      AIDS
    7. Izzedine, H; Launay-Vacher, V; Baumelou, A; Deray, G
      An appraisal of antiretroviral drugs in hemodialysis

      KIDNEY INTERNATIONAL
    8. Petersen, L; Pedersen, EB; Nielsen, C
      Three routes for the synthesis of 6-benzyl-1-ethoxymethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde

      SYNTHESIS-STUTTGART
    9. Cirelli, A; Cirelli, G; Scavalli, AS; Masciangelo, R; Marini, M
      Dual-energy X-ray absorptiometry in the early diagnosis of body shape changes in patients with HIV infection treated with nucleoside reverse transcriptase inhibitors and naive to protease inhibitors

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    10. McDermott, AY; Shevitz, A; Knox, T; Roubenoff, R; Kehayias, J; Gorbach, S
      Effect of highly active antiretroviral therapy on fat, lean, and bone massin HIV-seropositive men and women

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    11. van der Ende, ME; Guillon, C; Boers, PHM; Ly, TD; Gruters, RA; Osterhaus, ADME; Schutten, M
      Antiviral resistance of biologic HIV-2 clones obtained from individuals onnucleoside reverse transcriptase inhibitor therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Morlat, P; Marimoutou, C; Dequae-Merchadou, L; Pellegrin, I; Mercie, I; Neau, D; Beylot, J; Dabis, F
      Dual nucleoside regimens in nonadvanced HIV infection: Prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Sluis-Cremer, N; Arion, D; Parniak, MA
      Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs)

      CELLULAR AND MOLECULAR LIFE SCIENCES
    14. Aymard, G; Legrand, M; Trichereau, N; Diquet, B
      Determination of twelve antiretroviral agents in human plasma sample usingreversed-phase high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    15. Wimer, BM; Mann, PL
      Mitogen immunotherapy for HIV infections exemplified by phytohemagglutininand pokeweed mitogen

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    16. ter Hofstede, HJM; de Marie, D; Foudraine, NA; Danner, SA; Brinkman, K
      Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases

      INTERNATIONAL JOURNAL OF STD & AIDS
    17. Richard, N; Salomon, H; Oliveira, M; Rando, R; Mansour, T; Gu, ZX; Wainberg, MA
      Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    18. Chamorro, C; De Clercq, E; Balzarini, J; Camarasa, MJ; San-Felix, A
      TSAO-T analogues bearing amino acids at position N-3 of thymine: synthesisand anti-human immunodeficiency virus activity

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    19. Mestres, J; Rohrer, DC; Maggiora, GM
      A molecular-field-based similarity study of non-nucleoside HIV-1 reverse transcriptase inhibitors. 2. The relationship between alignment solutions obtained from conformationally rigid and flexible matching

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    20. Puig, T; Perez-Olmeda, M; Rubio, A; Ruiz, L; Briones, C; Franco, JM; Gomez-Cano, M; Stuyver, L; Zamora, L; Alvarez, C; Leal, M; Clotet, B; Soriano, V
      Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

      AIDS
    21. Casado, JL; Hertogs, K; Ruiz, L; Dronda, F; Van Cauwenberge, A; Arno, A; Garcia-Arata, I; Bloor, S; Bonjoch, A; Blazquez, J; Clotet, B; Larder, B
      Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen

      AIDS
    22. Samuel, R; Suh, B
      Antiretroviral therapy 2000

      ARCHIVES OF PHARMACAL RESEARCH
    23. Balzarini, J
      Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitors

      PHARMACOLOGY & THERAPEUTICS
    24. Kakuda, TN
      Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity

      CLINICAL THERAPEUTICS
    25. Pedersen, OS; Pedersen, EB
      Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    26. Mestres, J; Rohrer, DC; Maggiora, GM
      A molecular-field-based similarity study of non-nucleoside HIV-1 reverse transcriptase inhibitors

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    27. Gueglio, B; Billaud, E; Bani-Sadr, F; Allavena, C; Francois, C; Reliquet, V; Huart, A; Besnier, M; Leaute, S; Milpied, B; Raffi, F
      HIV highly active antiretroviral therapy: 144 patients followed up in a reference center for AIDS in western France (Nantes Hospital).

      MEDECINE ET MALADIES INFECTIEUSES
    28. Gianotti, N; Moretti, F; Tambussi, G; Capiluppi, B; Ferrari, M; Lazzarin, A
      The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogs

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    29. de Jong, JJ; Goudsmit, J; Lukashov, VV; Hillebrand, ME; Baan, E; Huismans, R; Danner, SA; ten Veen, JH; de Wolf, F; Jurriaans, S
      Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs

      AIDS
    30. Lawtrakul, L; Hannongbua, S; Beyer, A; Wolschann, P
      Molecular calculations on the conformation of the HIV-1 reverse transcriptase inhibitor 1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine (HEPT)

      MONATSHEFTE FUR CHEMIE
    31. De Clercq, E
      Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection

      FARMACO
    32. VIDAL C; GARCIA F; GATELL JM; LEAL M; CLOTET B; PUMAROLA T; MIRO JM; MALLOLAS J; RUIZ L; CRUCETA A; TORTAJADA C
      PREDICTIVE FACTORS INFLUENCING PEAK VIRAL LOAD DROP IN RESPONSE TO NUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR-5 IN ANTIRETROVIRAL-NAIVE HIV-1-INFECTED PATIENTS

      Journal of acquired immune deficiency syndromes and human retrovirology
    33. PETER K; GAMBERTOGLIO JG
      INTRACELLULAR PHOSPHORYLATION OF ZIDOVUDINE (ZDV) AND OTHER NUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS (RTI) USED FOR HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION

      Pharmaceutical research
    34. MILLER V; STURMER M; STASZEWSKI S; GROSCHEL B; HERTOGS K; DEBETHUNE MP; PAUWELS R; HARRIGAN PR; BLOOR S; KEMP SD; LARDER BA
      THE M184V MUTATION IN HIV-1 REVERSE-TRANSCRIPTASE (RT) CONFERRING LAMIVUDINE RESISTANCE DOES NOT RESULT IN BROAD CROSS-RESISTANCE TO NUCLEOSIDE ANALOG RT INHIBITORS

      AIDS
    35. DECLERCQ E
      NEW PERSPECTIVES FOR THE TREATMENT OF HIV-INFECTIONS

      Collection of Czechoslovak Chemical Communications
    36. MAYERS D
      RATIONAL APPROACHES TO RESISTANCE - NUCLEOSIDE ANALOGS

      AIDS
    37. SAHAI J
      RISKS AND SYNERGIES FROM DRUG-INTERACTIONS

      AIDS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 18:34:51